HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chih-Cheng Chen Selected Research

N-phenacylthiazolium bromide

10/2015Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chih-Cheng Chen Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 02/2005
24Pain (Aches)
01/2022 - 06/2002
14Hyperalgesia
01/2022 - 04/2007
11Myalgia
01/2022 - 08/2010
10Inflammation (Inflammations)
01/2022 - 01/2009
9Hypertension (High Blood Pressure)
03/2018 - 08/2010
7Infections
08/2021 - 10/2011
7Obesity
01/2021 - 04/2017
7Body Weight (Weight, Body)
10/2020 - 08/2011
6Fibromyalgia (Fibrositis)
01/2022 - 01/2015
6Acidosis
01/2019 - 10/2007
5Sepsis (Septicemia)
01/2021 - 04/2012
5Cholestasis
02/2013 - 02/2009
4Pneumonia (Pneumonitis)
11/2022 - 01/2020
4Fibrosis (Cirrhosis)
10/2022 - 01/2011
4Chronic Pain
01/2022 - 07/2011
4Asthma (Bronchial Asthma)
01/2020 - 01/2007
3Splenomegaly
10/2022 - 04/2021
3Hemophilia A (Haemophilia)
03/2022 - 09/2003
3Hypersensitivity (Allergy)
01/2022 - 01/2014
3Fever (Fevers)
08/2021 - 11/2016
3Primary Myelofibrosis (Myelosclerosis)
04/2021 - 12/2014
3Neuralgia (Stump Neuralgia)
11/2020 - 04/2007
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2020 - 12/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 01/2016
3Ischemia
05/2018 - 01/2011
3Liver Diseases (Liver Disease)
11/2016 - 04/2010
3Insulin Resistance
04/2016 - 07/2008
3Stomach Neoplasms (Stomach Cancer)
10/2013 - 01/2012
2Thrombocytopenia (Thrombopenia)
10/2022 - 11/2021
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2021 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2014
2Multiple Myeloma
01/2019 - 09/2017
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 11/2016
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 01/2017
2Birth Weight (Birth Weights)
01/2018 - 02/2015
2Hypoxia (Hypoxemia)
01/2017 - 01/2011
2Necrosis
01/2017 - 12/2014
2Leukemia
01/2017 - 01/2008
2Allergic Rhinitis
12/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

19AcidsIBA
01/2022 - 08/2010
13Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 01/2014
12Acid Sensing Ion ChannelsIBA
01/2022 - 10/2007
8Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
7Air Pollutants (Pollutants, Air)IBA
11/2021 - 01/2007
7GlucocorticoidsIBA
08/2021 - 01/2014
7Environmental Pollutants (Pollutants, Environmental)IBA
01/2020 - 01/2007
5Substance PIBA
01/2022 - 01/2012
5Messenger RNA (mRNA)IBA
10/2021 - 09/2003
5CytokinesIBA
08/2021 - 05/2006
5Interleukin-6 (Interleukin 6)IBA
12/2020 - 03/2010
5Drinking WaterIBA
07/2012 - 01/2010
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2008
4Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2015
4RNA (Ribonucleic Acid)IBA
02/2021 - 12/2014
4Biological ProductsIBA
12/2020 - 09/2006
4ResveratrolIBA
07/2020 - 04/2019
4N,N-dimethylarginine (asymmetric dimethylarginine)IBA
02/2016 - 04/2010
4MelatoninIBA
01/2015 - 02/2009
4CalciumIBA
07/2012 - 01/2010
4MagnesiumIBA
07/2012 - 01/2010
3OzoneIBA
01/2022 - 01/2018
3EnzymesIBA
11/2021 - 02/2016
3Analgesics (Analgesic Drugs)IBA
10/2019 - 01/2015
3NeuropeptidesIBA
10/2019 - 05/2014
3LeptinIBA
04/2019 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
01/2019 - 06/2008
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018 - 10/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 - 04/2014
3Arachidonic Acid (Vitamin F)IBA
01/2016 - 10/2010
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2011 - 08/2010
2Factor VIII (Coagulation Factor VIII)IBA
03/2022 - 09/2003
2CollagenIBA
01/2022 - 05/2015
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 08/2021
2Inosine Triphosphate (ITP)IBA
11/2021 - 01/2017
2AntibodiesIBA
11/2021 - 11/2020
2ChemokinesIBA
08/2021 - 01/2020
2MethylprednisoloneFDA LinkGeneric
08/2021 - 06/2008
2Particulate MatterIBA
01/2021 - 01/2018
2C-Reactive ProteinIBA
01/2021 - 01/2020
2AntioxidantsIBA
12/2020 - 04/2014
2Surface-Active Agents (Surfactants)IBA
10/2020 - 02/2015
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2016
2Nitrogen DioxideIBA
01/2018 - 01/2008
2Fatty Acids (Saturated Fatty Acids)IBA
04/2017 - 05/2006
2SodiumIBA
04/2017 - 01/2009
2InterleukinsIBA
01/2017 - 08/2011
2Pharmaceutical PreparationsIBA
01/2017 - 06/2012
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2017 - 12/2014
2CalreticulinIBA
01/2017 - 12/2014
2Protons (Proton)IBA
01/2017 - 10/2007
2Transaminases (Aminotransferases)IBA
11/2016 - 08/2004

Therapy/Procedure

10Therapeutics
08/2021 - 09/2006
8Ligation
10/2020 - 02/2009
4Radiotherapy
01/2019 - 06/2009
3Catheters
01/2021 - 11/2015
2Hematopoietic Stem Cell Transplantation
11/2022 - 08/2004
2Analgesia
01/2022 - 10/2019
2Injections
01/2022 - 01/2019
2Transjugular Intrahepatic Portasystemic Shunt
11/2020 - 01/2018